Los Angeles - Cutaneous atrophy, the bane of topical corticosteroid treatment, may have met its match in a thyroid hormone analogue, according to Jan Faergemann, M.D., Ph.D.
Evaluating Efficacy of Trifarotene in Latin American Patients With Acne
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Understanding Eyebrow and Eyelash Hair Loss in Severe Alopecia Areata
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Data-Driven Advice for Health Care Workers Experiencing Contact Dermatitis
Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline